![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, July 15, 2023 7:23:03 AM
So I hope that our intended partner in our business combination is PCI Pharma, and that we can conclude negotiations, and perhaps end up with an equity stake in a company that could become our product manufacturer, and more.
Whether there is any intent on using PCI Pharma in this capacity, or not, I couldn't say. But our success can't be held hostage. There are other CDMO's, and perhaps Cenexi is still a possibility. We need a Plan B, if not as a business combination candidate, then at least as a CDMO.
I fully support dedicating up to 40% of the company to a business combination into an entity that we will co-own, if that means we have ownership rights over the manufacture of our product. If the Baudax investment leads to Recro, that could also be our key to a CDMO foothold.
I think that management has amazing foresight, and I'm not used to seeing them at an impasse, which I hope they can overcome.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM